Sectoral Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,800
| Closed | -$242K | – | 103 |
|
|
2024
Q1 | $242K | Sell |
8,800
-500
| -5% | -$13.8K | 0.1% | 87 |
|
|
2023
Q4 | $284K | Sell |
9,300
-103,032
| -92% | -$3.14M | 0.12% | 93 |
|
|
2023
Q3 | $3.55M | Buy |
112,332
+11,500
| +11% | +$364K | 0.69% | 62 |
|
|
2023
Q2 | $4.11M | Buy |
100,832
+98,352
| +3,966% | +$4.01M | 0.69% | 64 |
|
|
2023
Q1 | $92.4K | Sell |
2,480
-68,900
| -97% | -$2.57M | 0.02% | 117 |
|
|
2022
Q4 | $2.49M | Hold |
71,380
| – | – | 0.48% | 71 |
|
|
2022
Q3 | $3.99M | Hold |
71,380
| – | – | 0.79% | 59 |
|
|
2022
Q2 | $3.7M | Sell |
71,380
-820
| -1% | -$42.4K | 0.74% | 59 |
|
|
2022
Q1 | $5.25M | Buy |
72,200
+600
| +0.8% | +$43.6K | 0.93% | 40 |
|
|
2021
Q4 | $8.47M | Buy |
71,600
+8,700
| +14% | +$1.03M | 1.27% | 31 |
|
|
2021
Q3 | $8.44M | Buy |
+62,900
| New | +$8.44M | 0.7% | 60 |
|
|
2016
Q4 | – | Sell |
-123,159
| Closed | -$2.32M | – | 59 |
|
|
2016
Q3 | $2.32M | Hold |
123,159
| – | – | 0.23% | 51 |
|
|
2016
Q2 | $1.47M | Buy |
+123,159
| New | +$1.47M | 0.15% | 57 |
|